6Khan MA,Mudassara M,Shazia F,et al.Prediction of response to neoadjuvant chemotherapy in locally advanced breast cancer with scintimammography and its correlation with P-glycoprotein levels.World J Nucl Med,2009,8:262.
7Young H,Baum R,Cremerius U,et al.Measurement of clinical and subclinical tumor response using 18F-fluorodexyglucose and positron emission tomography:review and 1999 EORTC recommendations,Eur J Cancer,1999,35:1773-1782.
8Wahl RL,Jacene H,Kasamon Y,et al.From RECIST to PERCIST:evolving considerations for PET response criteria in solid tumors.J Nucl Med,2009,50:122s-150s.
9Dhital K, Saunders CA, Seed PT, et al. 18 F-FDG PET and its prognostic value in lung cancer. Eur J Cardiothorac Surg, 2000, 18: 425-428.
10Menda Y, Bushnell DL, Madsen MT, et al. Evaluation of various correc tion to the standardized uptake value for diagnosis of pulmonary malignancy.Nucl Med Commun, 2001, 22: 1077-1081.
1Deantonio L,Beldi D,Gambaro G,et al.FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma.Radiat Oncol,2008,3:29-32.
2Pio BS,Park CK,Pietras R,et al.Usefulness of 3'-[F-18] fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy.Mol Imaging Biol,2006,8:36-42.
3Brepoels L,Stroobants S.PET scanning and prognosis in Hodgkin's lymphoma Current Opinion in Oncology,2008,20:509-516.
4Itti E,Lin C,Dupuis J,et al.Prognostic value of interim ^18F-FDG PET in patients with diffuse large B-cell lymphoma:SU V-based assessment at 4 cycles of chemotherapy.J Nucl Med,2009,50:527-533.
5Lin C,Itti E,Haioun C,et al.Early 18F-FDG PET for prediction of prognosis in patients with diffuse large B-cell lymphoma:SUV-based assessment versus visual analysis.J Nucl Med,2007,48:1580-1582.
6Prévost S,Boucher L,Lariv ée P,et al.Bone marrow hypermetabolism on 18F-FDG PET as a survival prognostic factor in non-small cell lung cancer.J Nuel Med,2006,47:1901-1902.
7Guo H,Zhu H,Xi Y,et al.Diagnostic and prognostic value of ^18F-FDG PET/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus.J Nucl Med,2007,48:1251-1258.
8van der Veldt AA,Buist MR,van Baal MW.Clarifying the diagnosis of clinically suspected recurrence of cervical cancer:impact of 18F-FDG PET.J Nucl Med,2008,49:1936-1943.
9Basu S.From pure research imaging tool to PET-guided personalized medicine in oncology:A true revolution in modern medicine.Indian J Cancer,2010,47:98-99.
10Ebright MI, Russo GA, Gupta A, et al. Positron emission tomo- graphy combined with diagnostic chest computed tomography en- hances detection of regional recurrence after stereotactic body radia- tion therapy for early stage non-small cell lung cancer[ J]. J Thorac Cardiovasc Surg, 2013, 145(3): 709-715.
